Table 3 The results for each histological subtype when applying the model to the training set.

From: A prediction model using 2-propanol and 2-butanone in urine distinguishes breast cancer

BCP

HC

Subtype

True positive

False negative

Sensitivity (%)

True negative

False positive

Specificity (%)

Luminal A-like

17

1

94.4

50

10

83.3

Luminal B-like

17

1

94.4

Luminal HER2-like

8

0

100.0

Pure HER2-like

4

0

100.0

Triple-negative-like

10

1

90.9

  1. BCP breast cancer patients, HC healthy controls.